What is this that has people going gaga
and experts trying to get their names out in front to be part of a
new commission? It seems a yet to be passed congressional
legislation is to blame. First it will have to be passed by the
House and Senate and be signed by the President. Chances seem
average for this to happen, but probably not until after the
election. In a letter from my congressional representative, he
stated that it was highly doubtful anything would happen in the
current year. Once again, patients are not called upon to serve and
lend their voices.
If passed, it will establish the
National Diabetes Clinical Care Commission (NDCCC). Under the Senate
version, the NDCCC will include diabetes experts and other health
care providers who work directly with diabetes patients. Also
included will be patient advocates and representatives from the
federal agencies most involved in diabetes care activities. Yet
unknown is the actual number of commission members. Hopefully,
non-government members will out number government members.
If passed, the NDCCC will have the
responsibility of evaluating current federal quality improvement
initiatives and identify redundant and ineffective policies. The
NDCCC will also determine which policies are effective, if any. The
commission will make recommendations to the Secretary of Health and
Human Services and to the Congress on new approaches and the
consolidation of existing operations. The claim is made that this
will help leverage the federal investment in diabetes research. Past
leverages of diabetes research has reduced the number of test strips
people with diabetes are allowed to be reimbursed for so I have
doubts that this will improve patient outcomes or reduce to burden of
diabetes.
The act is endorsed by the major
diabetes organizations, including the Pediatric Endocrine Society,
the Endocrine Society, the American Academy of Ophthalmology, and the
American Diabetes Association, in addition to the AACE and JDRF. You
have to know that these groups want to have representatives on the
commission. These groups are rule and guideline oriented and will do
nothing to enhance to patients' position and lend efficiency to the
government agencies. Everything will be aimed at the average patient
and nothing will be done for the individual differences and providing
assistance for patients that vary outside the “norm”.
Tom Ross at notmedicatedyet has an
excellent blog about this topic. Even with his forewarning, I was
not able to get any information from the site that he had a problem
with even though I tried to get it to print. I will only add that
what I was able to read was interesting.
This piece of congressional legislation
will be of benefit only to those who serve and will do nothing for
the patient population to prevent diabetes or assist those already
having diabetes. If it is passed, it will not be of benefit for
those needing help, only the rule and guideline makers who serve on
the commission. Once again, the patients that are needing a voice in
our government will be left wanting.